These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 3373218)

  • 1. Differential alteration of various cholinergic markers in cortical and subcortical regions of human brain in Alzheimer's disease.
    Araujo DM; Lapchak PA; Robitaille Y; Gauthier S; Quirion R
    J Neurochem; 1988 Jun; 50(6):1914-23. PubMed ID: 3373218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of aging on nicotinic and muscarinic autoreceptor function in the rat brain: relationship to presynaptic cholinergic markers and binding sites.
    Araujo DM; Lapchak PA; Meaney MJ; Collier B; Quirion R
    J Neurosci; 1990 Sep; 10(9):3069-78. PubMed ID: 2398371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative alterations of nicotinic and muscarinic binding sites in Alzheimer's and Parkinson's diseases.
    Aubert I; Araujo DM; Cécyre D; Robitaille Y; Gauthier S; Quirion R
    J Neurochem; 1992 Feb; 58(2):529-41. PubMed ID: 1729398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of chronic nicotine treatment on nicotinic autoreceptor function and N-[3H]methylcarbamylcholine binding sites in the rat brain.
    Lapchak PA; Araujo DM; Quirion R; Collier B
    J Neurochem; 1989 Feb; 52(2):483-91. PubMed ID: 2911027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered muscarinic and nicotinic receptor densities in cortical and subcortical brain regions in Parkinson's disease.
    Lange KW; Wells FR; Jenner P; Marsden CD
    J Neurochem; 1993 Jan; 60(1):197-203. PubMed ID: 8417140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Muscarinic and nicotinic cholinergic binding sites in Alzheimer's disease cerebral cortex.
    Kellar KJ; Whitehouse PJ; Martino-Barrows AM; Marcus K; Price DL
    Brain Res; 1987 Dec; 436(1):62-8. PubMed ID: 3690354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in nicotinic and muscarinic cholinergic receptors in Alzheimer-type dementia.
    Shimohama S; Taniguchi T; Fujiwara M; Kameyama M
    J Neurochem; 1986 Jan; 46(1):288-93. PubMed ID: 3940287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of N-[3H]methylcarbamylcholine binding sites and effect of N-methylcarbamylcholine on acetylcholine release in rat brain.
    Araujo DM; Lapchak PA; Collier B; Quirion R
    J Neurochem; 1988 Jul; 51(1):292-9. PubMed ID: 3379410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative ontogenic profile of cholinergic markers, including nicotinic and muscarinic receptors, in the rat brain.
    Aubert I; Cécyre D; Gauthier S; Quirion R
    J Comp Neurol; 1996 May; 369(1):31-55. PubMed ID: 8723701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Muscarinic cholinergic receptor subtypes in the human brain. II. Quantitative autoradiographic studies.
    Cortés R; Probst A; Tobler HJ; Palacios JM
    Brain Res; 1986 Jan; 362(2):239-53. PubMed ID: 3753655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 192IGG-saporin-induced selective lesion of cholinergic basal forebrain system: neurochemical effects on cholinergic neurotransmission in rat cerebral cortex and hippocampus.
    Rossner S; Schliebs R; Härtig W; Bigl V
    Brain Res Bull; 1995; 38(4):371-81. PubMed ID: 8535860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colchicine administered into the area of the nucleus basalis decreases cortical nicotinic cholinergic receptors labelled by [3H]-acetylcholine.
    Tilson HA; Schwartz RD; Ali SF; McLamb RL
    Neuropharmacology; 1989 Aug; 28(8):855-61. PubMed ID: 2779754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple cholinergic markers are unexpectedly not altered in the rat dentate gyrus following entorhinal cortex lesions.
    Aubert I; Poirier J; Gauthier S; Quirion R
    J Neurosci; 1994 May; 14(5 Pt 1):2476-84. PubMed ID: 8182423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neocortical cholinergic enzyme and receptor activities in the human fetal brain.
    Perry EK; Smith CJ; Atack JR; Candy JM; Johnson M; Perry RH
    J Neurochem; 1986 Oct; 47(4):1262-9. PubMed ID: 3746300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholinergic markers in aged cognitively impaired Long-Evans rats.
    Aubert I; Rowe W; Meaney MJ; Gauthier S; Quirion R
    Neuroscience; 1995 Jul; 67(2):277-92. PubMed ID: 7675169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Muscarinic and nicotinic receptor changes in the cortex and thalamus of brains of chronic alcoholics.
    Hellström-Lindahl E; Winblad B; Nordberg A
    Brain Res; 1993 Aug; 620(1):42-8. PubMed ID: 8402197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Muscarinic cholinergic receptor subtypes in normal human brain and Alzheimer's presenile dementia.
    Vanderheyden P; Ebinger G; Dierckx R; Vauquelin G
    J Neurol Sci; 1987 Dec; 82(1-3):257-69. PubMed ID: 3440867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of high-affinity agonist binding to M1 muscarinic receptors in Alzheimer's disease: implications for the failure of cholinergic replacement therapies.
    Flynn DD; Weinstein DA; Mash DC
    Ann Neurol; 1991 Mar; 29(3):256-62. PubMed ID: 2042942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional distribution of muscarinic and nicotinic cholinergic receptor binding activities in the human brain.
    Perry EK; Smith CJ; Perry RH; Whitford C; Johnson M; Birdsall NJ
    J Chem Neuroanat; 1989; 2(4):189-99. PubMed ID: 2597358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Muscarinic receptor plasticity in rats lesioned in the nucleus basalis of Meynert.
    Vige X; Briley M
    Neuropharmacology; 1989 Jul; 28(7):727-32. PubMed ID: 2761681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.